Search Results 7001-7010 of 25233 for oral
Oral decitabine-cedazuridine versus intravenous decitabine for myelodysplastic syndromes and chronic myelomonocytic leukaemia (ASCERTAIN): a registrational ...
* Patient must not be on any concomitant anticoagulation with oral anticoagulants or platelet inhibitors, except for the following allowed agents: * Low ...
Has a history of a gastrointestinal condition or procedure that in the opinion of the Investigator may affect oral drug absorption. Note: Other protocol ...
Liver function and portal-systemic shunting quantified by the oral cholate challenge test and risk for large oesophageal varices. Aliment Pharmacol Ther ...
Patients randomized to GDC-0199+R will be given GDC-0199 daily (oral, target dose 400 mg) and will receive 6 cycles of rituximab infused intravenously (IV) ...
... Oral and throat cancer, Adenocarcinoma, Laryngeal cancer, Carotid body tumor, Tongue base cancer, Mouth tumor, Salivary gland cancer, Parotid cancer ...
Insertion of intra-oral electrodes for cranial nerve monitoring using a Crowe-Davis retractor. J Clin Monit Comput. 2017 Aug; 31 (4):793-796 Epub 2016 July ...
romelalgia, Rosacea, Oral lichen planus, Chronic hives, Contact dermatitis, Stevens-Johnson syndrome. Show more areas of focus for Mark Denis P. Davis, M.D. ...
These patients may require chronic use of oral steroids. Difficult-to-control asthma in children accounts for significant morbidity and health care costs ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.